|
End-of-day quote
Shanghai S.E.
31/08/2026
|
5-day change | 1st Jan Change | ||
| 14.68 CNY | -1.41% |
|
-1.94% | -2.59% |
| 08-24 | Tasly Pharmaceutical to Buy 4 Billion Yuan of Wealth Management Products | MT |
| 08-24 | Tasly Pharmaceutical's Subsidiary Secures Nod to Trial TSL2402 Tablets | MT |
| Market Cap | 21.93B 3.26B 2.81B 2.64B 2.41B 4.52B 310B 4.55B 31.25B 12.16B 157B 12.25B 11.98B 521B | P/E 2026 * |
16x | P/E 2027 * | 13.3x |
|---|---|---|---|---|---|
| Enterprise Value | 20.39B 3.03B 2.61B 2.45B 2.24B 4.2B 288B 4.23B 29.05B 11.3B 146B 11.38B 11.14B 484B | EV / Sales 2026 * |
2.38x | EV / Sales 2027 * | 1.74x |
| Free-Float |
47.11% | Yield 2026 * |
2.81% | Yield 2027 * | 3.52% |
| 1 day | -1.41% | ||
| 1 week | -1.94% | ||
| Current month | -8.93% | ||
| 1 month | -7.56% | ||
| 3 months | +4.34% | ||
| 6 months | +2.73% | ||
| Current year | -2.59% |
| 1 week | 14.59 | 15.04 | |
| 1 month | 14.59 | 16.22 | |
| Current year | 12.9 | 16.24 | |
| 1 year | 12.9 | 16.72 | |
| 3 years | 12.24 | 18 | |
| 5 years | 9.2 | 18 | |
| 10 years | 9.2 | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 08/05/2024 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 09/07/2018 |
Xin Yang
CIO | Chief Investment Officer | 45 | 01/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Jian Wang
BRD | Director/Board Member | 72 | 02/06/2021 |
Jin Yong Cai
CHM | Chairman | 54 | 10/08/2026 |
Ke Xin Li
BRD | Director/Board Member | 58 | 08/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.41% | -1.94% | -11.14% | +5.99% | 3.31B | ||
| +0.78% | +2.15% | -12.49% | -6.96% | 13.26B | ||
| -2.41% | +0.50% | -33.04% | -56.86% | 4.99B | ||
| -3.11% | -1.57% | -8.27% | -7.32% | 4.66B | ||
| -1.55% | -3.16% | -2.75% | -31.25% | 4.02B | ||
| -1.07% | +1.95% | -21.84% | +3.65% | 3.59B | ||
| +3.31% | +6.11% | +0.23% | -0.92% | 3.43B | ||
| -1.65% | -3.87% | -23.53% | -14.45% | 2.38B | ||
| -1.52% | +1.41% | -27.89% | -15.73% | 1.72B | ||
| -1.33% | +2.78% | -1.99% | -14.29% | 1.7B | ||
| Average | -1.00% | -0.02% | -14.27% | -13.81% | 4.31B | |
| Weighted average by Cap. | -0.66% | -0.06% | -13.98% | -13.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.56B 1.27B 1.1B 1.03B 940M 1.77B 121B 1.78B 12.2B 4.75B 61.44B 4.78B 4.68B 203B | 9.32B 1.39B 1.19B 1.12B 1.02B 1.92B 132B 1.94B 13.28B 5.17B 66.88B 5.2B 5.09B 221B |
| Net income | 1.37B 204M 176M 165M 151M 283M 19.44B 285M 1.96B 761M 9.86B 767M 750M 32.63B | 1.65B 246M 212M 199M 181M 341M 23.38B 343M 2.35B 916M 11.86B 923M 903M 39.26B |
| Net Debt | -1.54B -230M -198M -186M -169M -318M -21.85B -321M -2.2B -856M -11.08B -862M -843M -36.68B | -5.71B -850M -731M -687M -627M -1.18B -80.83B -1.19B -8.14B -3.17B -40.99B -3.19B -3.12B -136B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/08/26 | CN¥14.68 | -1.41% | 16,219,530 |
| 28/08/26 | CN¥14.89 | +0.47% | 15,263,887 |
| 27/08/26 | CN¥14.82 | +0.34% | 13,596,225 |
| 26/08/26 | CN¥14.77 | +0.14% | 13,777,567 |
| 25/08/26 | CN¥14.75 | -0.47% | 12,437,989 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600535 Stock
Select your edition
All financial news and data tailored to specific country editions
















